Literature DB >> 17433918

An in vitro model of stroke-induced epilepsy: elucidation of the roles of glutamate and calcium in the induction and maintenance of stroke-induced epileptogenesis.

Robert J DeLorenzo1, David A Sun, Robert E Blair, Sompong Sombati.   

Abstract

Stroke is a major risk factor for developing acquired epilepsy (AE). Although the underlying mechanisms of ischemia-induced epileptogenesis are not well understood, glutamate has been found to be associated with both epileptogenesis and ischemia-induced injury in several research models. This chapter discusses the development of an in vitro model of epileptogenesis induced by glutamate injury in hippocampal neurons, as found in a clinical stroke, and the implementation of this model of stroke-induced AE to evaluate calcium's role in the induction and maintenance of epileptogenesis. To monitor the acute effects of glutamate on neurons and chronic alterations in neuronal excitability up to 8 days after glutamate exposure, whole-cell current-clamp electrophysiology was employed. Various durations and concentrations of glutamate were applied to primary hippocampal cultures. A single 30-min, 5-microM glutamate exposure produced a subset of neurons that died or had a stroke-like injury, and a larger population of injured neurons that survived. Neurons that survived the injury manifested spontaneous, recurrent, epileptiform discharges (SREDs) in neural networks characterized by paroxysmal depolarizing shifts (PDSs) and high-frequency spike firing that persisted for the life of the culture. The neuronal injury produced in this model was evaluated by determining the magnitude of the prolonged, reversible membrane depolarization, loss of synaptic activity, and neuronal swelling. The permanent epileptiform phenotype expressed as SREDs that resulted from glutamate injury was found to be dependent on the presence of extracellular calcium. The "epileptic" neurons manifested elevated intracellular calcium levels when compared to control neurons, independent of neuronal activity and seizure discharge, demonstrating that alterations in calcium homeostatic mechanisms occur in association with stroke-induced epilepsy. Findings from this investigation present the first in vitro model of glutamate injury-induced epileptogenesis that may help elucidate some of the mechanisms that underlie stroke-induced epilepsy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17433918     DOI: 10.1016/S0074-7742(06)81005-6

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  12 in total

1.  An organotypic hippocampal slice culture model of excitotoxic injury induced spontaneous recurrent epileptiform discharges.

Authors:  Julie M Ziobro; Laxmikant S Deshpande; Robert J Delorenzo
Journal:  Brain Res       Date:  2010-11-25       Impact factor: 3.252

2.  Network hyperexcitability in hippocampal slices from Mecp2 mutant mice revealed by voltage-sensitive dye imaging.

Authors:  Gaston Calfa; John J Hablitz; Lucas Pozzo-Miller
Journal:  J Neurophysiol       Date:  2011-02-09       Impact factor: 2.714

3.  Pharmacological blockade of the calcium plateau provides neuroprotection following organophosphate paraoxon induced status epilepticus in rats.

Authors:  Laxmikant S Deshpande; Robert E Blair; Beverly A Huang; Kristin F Phillips; Robert J DeLorenzo
Journal:  Neurotoxicol Teratol       Date:  2016-05-17       Impact factor: 3.763

4.  Neurofibromin Regulates Seizure Attacks in the Rat Pilocarpine-Induced Model of Epilepsy.

Authors:  Min Ren; Kunyi Li; Dan Wang; Jiamei Guo; Jing Li; Guang Yang; Xianghua Long; Wenjing Shen; Rong Hu; Xuefeng Wang; Kebin Zeng
Journal:  Mol Neurobiol       Date:  2015-11-04       Impact factor: 5.590

Review 5.  The adenosine kinase hypothesis of epileptogenesis.

Authors:  Detlev Boison
Journal:  Prog Neurobiol       Date:  2007-12-23       Impact factor: 11.685

6.  Magnolol reduces glutamate-induced neuronal excitotoxicity and protects against permanent focal cerebral ischemia up to 4 hours.

Authors:  Wei-Ting Lee; Miao-Hui Lin; E-Jian Lee; Yu-Chang Hung; Shih-Huang Tai; Hung-Yi Chen; Tsung-Ying Chen; Tian-Shung Wu
Journal:  PLoS One       Date:  2012-07-09       Impact factor: 3.240

Review 7.  5-HT3 Receptors: A Potential Therapeutic Target for Epilepsy.

Authors:  Hongyan Zhao; Yang Lin; Shurui Chen; Xin Li; Hongliang Huo
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 8.  The Function of the Mitochondrial Calcium Uniporter in Neurodegenerative Disorders.

Authors:  Yajin Liao; Yuan Dong; Jinbo Cheng
Journal:  Int J Mol Sci       Date:  2017-02-10       Impact factor: 5.923

9.  Therapeutic window for YC‑1 following glutamate‑induced neuronal damage and transient focal cerebral ischemia.

Authors:  Shih-Huang Tai; Wei-Ting Lee; Ai-Chiang Lee; Yu-Wen Lin; Hsin-Yi Hung; Sheng-Yang Huang; Tian-Shung Wu; E-Jian Lee
Journal:  Mol Med Rep       Date:  2018-03-01       Impact factor: 2.952

Review 10.  Metabotropic Glutamate Receptors and Interacting Proteins in Epileptogenesis.

Authors:  Feng Qian; Feng-Ru Tang
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.